RMTG Cellgenic unit begins commercial rollout in Colombia

Regenerative Medical Technology Group’s Cellgenic division began local commercial activity in Colombia, marking its third recently announced Latin American market.

Work includes establishing local representation, building relationships with physicians, and operating only through permitted channels under Colombian requirements.

Management flagged lead times for licensing, staffing, import logistics, and physician onboarding.

No revenue, physician-count, or demand guidance was provided; the update does not indicate product registration is complete.